Early Detection Research Network

Parity, oral contraceptives, and the risk of ovarian cancer among carriers and noncarriers of a BRCA1 or BRCA2 mutation.

No abstract available.

Beller U, Ben-Baruch G, Chetrit A, Fishman A, Hartge P, Hirsh-Yechezkel G, Lubin F, Menczer J, Modan B, Struewing JP, Tucker MA, Wacholder S


N. Engl. J. Med., 2001, 345 (4)